Is This Billion-Dollar Diabetes Drug Class Doomed?

In this edition of the Motley Fool's Market Checkup, health-care analysts David Williamson and Max Macaluso discuss the complex nuances of the type 2 diabetes market. From the most successful blockbusters on the market today to revolutionary experimental drugs, this is an increasingly competitive space that investors need to watch closely.

The following segment from this week's show focuses on Merck's (NYSE: MRK  ) billion-dollar type 2 diabetes drugs, Januvia and Janument. The growth of these blockbusters have helped Merck offset some of the recent losses it faced from the patent cliff, but sales have started to slow down and a study published this year in JAMA's Internal Medicine suggests that these drugs may increase the risk of pancreatitis. What should Merck shareholders be watching going forward?

If you're on the lookout for high-yielding stocks outside of the health-care sector, The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks. Grab your free copy today by clicking here.

The relevant video segment can be found between 2:50 and 4:46.

To view the entire show, click here.


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2511898, ~/Articles/ArticleHandler.aspx, 4/17/2014 3:13:36 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement